Search

everythinglearnresearchcommunity

for

Search:↓

Women with the NIH type of PCOS have more obesity and higher risk of diabetes and heart disease than those with other types of PCOS.

The guidelines advise against using testosterone and DHEA in women for most conditions due to safety and effectiveness concerns, but suggest considering testosterone for postmenopausal women with low sexual desire.

TGF-β is crucial for tissue repair and can cause diseases if not properly regulated.

Women with PCOS are more likely to have impaired glucose tolerance and type 2 diabetes, especially if they are Asian or obese.

Men are more likely to have severe COVID-19 cases and fatalities than women due to factors like lifestyle, aging, and biological differences.

The PDGF/PDGFR pathway is a potential drug target with mixed success in treating various diseases, including some cancers and fibrosis.

Special fiber materials boost the healing properties of certain stem cells.

Women with PCOS have heart-related issues not because of obesity, but due to insulin resistance and low adiponectin levels.

The WNT signaling pathway is important in many diseases and targeting it could offer new treatments.

Choosing the right patients, using proper techniques, and having thorough knowledge are key to preventing and managing dermal filler complications.

Potassium channel openers could help treat cardiovascular diseases and asthma but require better targeting to specific tissues for effective use.

The Wnt/β-catenin pathway is important for tissue development and has potential in regenerative medicine, but requires more research for therapeutic use.

Skin problems in COVID-19 patients are rare and may be due to the body's complex immune response or blood clotting issues.

Mesenchymal stem cells show potential for skin healing and anti-aging, but more research is needed for safe use, especially regarding stem cells from induced pluripotent sources.

5α-reductase inhibitors can cause sexual problems, higher risk of aggressive prostate cancer, and depression.

Electrospun nanofibers show promise for enhancing blood vessel growth in tissue engineering but need further research to improve their effectiveness.

Spironolactone improved blood vessel function and cholesterol levels in non-obese women with PCOS.

Botox increased hair count in men with baldness and might work by improving scalp blood flow.

Eclipta alba has many health benefits and contains compounds with potential for drug development.

Face-lifts can lead to complications like bleeding, nerve injury, skin death, hair loss, and rare infections, with careful surgery reducing risks.

Botulinum toxin has potential for treating various skin conditions and improving wound healing.

Low-dose oral minoxidil safely treats hair loss, with hypertrichosis as main side effect.

Drug repurposing is a cost-effective way to find new uses for existing drugs, speeding up treatment development.

The current system can't fully test all combination treatments, so alternative methods and regulatory flexibility are needed.

Prostaglandin E2 affects human platelet activity in complex ways that could lead to personalized heart disease treatments.

Microencapsulation helps protect and track therapeutic cells, showing promise for treating various diseases, but more work is needed to improve the technology.

Systemic Lupus Erythematosus has varied symptoms and is hard to diagnose, affecting many body parts and requiring careful clinical judgment.

Skin problems are common in lupus, important for diagnosis, and can be triggered by sunlight.

Women with androgen excess, especially those with PCOS, have a much higher risk of heart disease and stroke.

New resveratrol-related compounds show promise for treating various health issues but need more research for clinical use.